- Home
- DNLI vs ESBA Comparison
DNLI vs ESBA Comparison
Compare DNLI & ESBA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DNLI
- ESBA
- Stock Information
- Founded
- DNLI 2013
- ESBA N/A
- Country
- DNLI United States
- ESBA United States
- Employees
- DNLI N/A
- ESBA N/A
- Industry
- DNLI Biotechnology: Biological Products (No Diagnostic Substances)
- ESBA
- Sector
- DNLI Health Care
- ESBA
- Exchange
- DNLI Nasdaq
- ESBA NYSE
- Market Cap
- DNLI 1.9B
- ESBA 2.0B
- IPO Year
- DNLI 2017
- ESBA 2013
- Fundamental
- Price
- DNLI $13.21
- ESBA $7.48
- Analyst Decision
- DNLI Strong Buy
- ESBA
- Analyst Count
- DNLI 15
- ESBA 0
- Target Price
- DNLI $33.85
- ESBA N/A
- AVG Volume (30 Days)
- DNLI 1.3M
- ESBA 6.4K
- Earning Date
- DNLI 05-06-2025
- ESBA 01-01-0001
- Dividend Yield
- DNLI N/A
- ESBA 1.88%
- EPS Growth
- DNLI N/A
- ESBA 3.47
- EPS
- DNLI N/A
- ESBA 0.30
- Revenue
- DNLI N/A
- ESBA $762,039,000.00
- Revenue This Year
- DNLI N/A
- ESBA N/A
- Revenue Next Year
- DNLI $256.73
- ESBA N/A
- P/E Ratio
- DNLI N/A
- ESBA $24.86
- Revenue Growth
- DNLI N/A
- ESBA 0.78
- 52 Week Low
- DNLI $10.57
- ESBA $6.39
- 52 Week High
- DNLI $33.33
- ESBA $11.50
- Technical
- Relative Strength Index (RSI)
- DNLI 44.46
- ESBA 45.67
- Support Level
- DNLI $12.86
- ESBA $7.08
- Resistance Level
- DNLI $13.77
- ESBA $7.83
- Average True Range (ATR)
- DNLI 0.72
- ESBA 0.18
- MACD
- DNLI -0.08
- ESBA -0.01
- Stochastic Oscillator
- DNLI 32.29
- ESBA 6.98
About DNLI Denali Therapeutics Inc.
Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegeneration disease. The company's development programs include the LRRK2 Inhibitor Program, which develops brain penetrant small molecule LRRK2 inhibitor product candidates for Parkinson's disease. Its key products include DNL201, DNL151, DNL747, ATV (Antibody Transport Vehicle), ETV (Enzyme Transport Vehicle), and others.
About ESBA EMPIRE STATE REALTY OP LIM PARTNER
Empire State Realty OP LP is an NYC-focused real estate investment trust (REIT) that owns and operates a portfolio of well-leased, top-of-tier, modernized, amenitized, and well-located office, retail, and multifamily assets, conducts all of its business and owns substantially all of its assets. The firm operates in two segments, Real Estate and Observatory. Through the Real Estate segment, it offers services related to the ownership, management, operation, acquisition, repositioning and disposition of its real estate assets. Under the Observatory segment, it operates the two observatories of the Empire State Building. The company generates maximum revenue from the Real Estate segment.